Alto Neuroscience (ANRO) Short Interest Ratio & Short Volume $13.17 +0.45 (+3.54%) (As of 09/6/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Alto Neuroscience Short Interest DataAlto Neuroscience (ANRO) has a short interest of 3.12 million shares, representing 14.08% of the float (the number of shares available for trading by the public). This marks a -14.99% decrease in short interest from the previous month. The short interest ratio (days to cover) is 17.0, indicating that it would take 17.0 days of the average trading volume of 191,841 shares to cover all short positions.Current Short Interest3,120,000 sharesPrevious Short Interest3,670,000 sharesChange Vs. Previous Month-14.99%Dollar Volume Sold Short$29.30 millionShort Interest Ratio17.0 Days to CoverLast Record DateAugust 15, 2024Outstanding Shares26,884,000 sharesFloat Size22,160,000 sharesShort Percent of Float14.08%Today's Trading Volume240,418 sharesAverage Trading Volume191,841 sharesToday's Volume Vs. Average125% Short Selling Alto Neuroscience? Sign up to receive the latest short interest report for Alto Neuroscience and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartANRO Short Interest Over TimeANRO Days to Cover Over TimeANRO Percentage of Float Shorted Over Time Ad Paradigm Press Fmr CIA Advisor reveals PEACEMAKER superweaponKamala cannot get the “codes” to this superweapon. In Trump’s hands, it will restore America’s global dominance. It could also help Americans struggling under Bidenomics by potentially sending 5 military stocks SOARING. Historically, similar stocks have shot up 16,270% in just 18 months.Full details are in this announcement. Alto Neuroscience Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 8/15/20243,120,000 shares $29.30 million -15.0%14.1%17 $9.39 7/31/20243,670,000 shares $39.65 million +7.3%16.6%21.7 $10.81 7/15/20243,420,000 shares $49.59 million No Change15.5%27.4 $14.50 ANRO Short Interest - Frequently Asked Questions What is Alto Neuroscience's current short interest? Short interest is the volume of Alto Neuroscience shares that have been sold short but have not yet been closed out or covered. As of August 15th, investors have sold 3,120,000 shares of ANRO short. 14.08% of Alto Neuroscience's shares are currently sold short. Learn More on Alto Neuroscience's current short interest. What is a good short interest ratio for Alto Neuroscience? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ANRO shares currently have a short interest ratio of 17.0. Learn More on Alto Neuroscience's short interest ratio. What is a good short interest percentage for Alto Neuroscience? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 14.08% of Alto Neuroscience's floating shares are currently sold short. Is Alto Neuroscience's short interest increasing or decreasing? Alto Neuroscience saw a decrease in short interest in the month of August. As of August 15th, there was short interest totaling 3,120,000 shares, a decrease of 15.0% from the previous total of 3,670,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Alto Neuroscience's float size? Alto Neuroscience currently has issued a total of 26,884,000 shares. Some of Alto Neuroscience's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Alto Neuroscience currently has a public float of 22,160,000 shares. How does Alto Neuroscience's short interest compare to its competitors? 14.08% of Alto Neuroscience's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Alto Neuroscience: Ocular Therapeutix, Inc. (12.12%), Centessa Pharmaceuticals plc (1.46%), Sana Biotechnology, Inc. (26.20%), ANI Pharmaceuticals, Inc. (7.96%), Evotec SE (0.08%), Tango Therapeutics, Inc. (17.69%), Arcutis Biotherapeutics, Inc. (20.56%), Collegium Pharmaceutical, Inc. (19.55%), ARS Pharmaceuticals, Inc. (25.31%), Disc Medicine, Inc. (8.72%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.23 billion), Aptiv PLC ($2.50 billion), Royal Caribbean Cruises Ltd. ($2.48 billion), Paychex, Inc. ($2.25 billion), Moderna, Inc. ($2.17 billion), Cencora, Inc. ($2.12 billion), Tractor Supply ($1.93 billion), Onsemi ($1.82 billion), International Paper ($1.81 billion), and Rivian Automotive, Inc. ($1.72 billion). View all of the most shorted stocks. What does it mean to sell short Alto Neuroscience stock? Short selling ANRO is an investing strategy that aims to generate trading profit from Alto Neuroscience as its price is falling. ANRO shares are trading up $0.45 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Alto Neuroscience? A short squeeze for Alto Neuroscience occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ANRO, which in turn drives the price of the stock up even further. How often is Alto Neuroscience's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ANRO, twice per month. The most recent reporting period available is August, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Ocular Therapeutix Short Interest Data Centessa Pharmaceuticals Short Interest Data Sana Biotechnology Short Interest Data ANI Pharmaceuticals Short Interest Data Evotec Short Interest Data Tango Therapeutics Short Interest Data Arcutis Biotherapeutics Short Interest Data Collegium Pharmaceutical Short Interest Data ARS Pharmaceuticals Short Interest Data Disc Medicine Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:ANRO) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alto Neuroscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alto Neuroscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.